Mirae Asset Global Investments’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,444
Closed -$4.11K 1701
2025
Q3
$4.11K Buy
2,444
+7
+0.3% +$11 ﹤0.01% 1619
2025
Q2
$2.95K Buy
2,437
+337
+16% +$489 ﹤0.01% 1554
2025
Q1
$2.65K Buy
2,100
+9
+0.4% +$24 ﹤0.01% 1533
2024
Q4
$6.75K Sell
2,091
-178
-8% -$641 ﹤0.01% 1539
2024
Q3
$7.24K Buy
2,269
+399
+21% +$1.55K ﹤0.01% 1511
2024
Q2
$7.7K Sell
1,870
-55,190
-97% -$537K ﹤0.01% 1476
2024
Q1
$480K Buy
57,060
+7,723
+16% +$117K ﹤0.01% 1920
2023
Q4
$475K Buy
49,337
+3,319
+7% +$22.9K ﹤0.01% 1989
2023
Q3
$214K Buy
46,018
+57
+0.1% +$284 ﹤0.01% 2269
2023
Q2
$246K Sell
45,961
-118
-0.3% -$728 ﹤0.01% 2262
2023
Q1
$330K Sell
46,079
-40
-0.1% -$241 ﹤0.01% 2119
2022
Q4
$309K Buy
46,119
+22
+0% +$121 ﹤0.01% 2143
2022
Q3
$159K Buy
+46,097
New +$176K ﹤0.01% 2406

Other funds holding MGNX

Mirae Asset Global Investments's MGNX Position: Q4 2025 in Review

Mirae Asset Global Investments sold out of MacroGenics (MGNX) in Q4 2025, closing a stake of 2,444 shares — an estimated $4.11K sold.

Mirae Asset Global Investments first reported a position in MGNX in Q3 2022 and held it in 13 quarters. The position peaked at $480K in Q1 2024. 88 funds tracked by Wall St. Rank hold MGNX as of Q4 2025.

  • Mirae Asset Global Investments reported no remaining MacroGenics position as of Q4 2025 after selling out during the quarter.
  • Mirae Asset Global Investments sold 2,444 MacroGenics shares in Q4 2025, an estimated $4.11K.
  • Mirae Asset Global Investments first reported a position in MacroGenics in Q3 2022 and held it in 13 quarters.
  • Mirae Asset Global Investments's MacroGenics position peaked at $480K in Q1 2024.
  • 88 funds tracked by Wall St. Rank held MacroGenics as of Q4 2025.

Based on Mirae Asset Global Investments's 13F filing for Q4 2025, filed 26 Jan 2026.